Skin-Cap OTC psoriasis treatment contains undeclared corticosteroids -- FDA alert.
This article was originally published in The Tan Sheet
Executive Summary
SKIN-CAP OTC PSORIASIS PRODUCT CONTAINS UNDECLARED CORTICOSTEROIDS, FDA states in an Aug. 8 consumer alert. The agency says its analysis of Skin-Cap has shown the topical product contains "prescription levels of a potent topical steroid, clobetasol propionate." Individuals using the product are advised to "immediately contact their health care providers." Skin-Cap is manufactured by Cheminova International in Madrid, Spain and imported to the U.S. through several distributors.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning